DEA schedule
Is imatinib a controlled substance?
Federal schedule for imatinib from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Imatinib is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and imatinib is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted imatinib?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 45 prescription listings from 22 labelers, none with a DEA schedule |
| DEA controlled substances list | imatinib is not on the list |
Imatinib NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0078-0401 | Gleevec | tablet | 100 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0649 | Gleevec | tablet | 400 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-1490 | Gleevec | tablet | 400 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 81927-201 | IMKELDI | solution | 80 mg/mL | Shorla Oncology Inc., | None |
| 0832-0532 | imatinib mesylate | tablet | 100 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 67184-0532 | imatinib mesylate | tablet | 100 mg/1 | Qilu Pharmaceutical Co., Ltd. | None |
| 72819-185 | imatinib mesylate | tablet | 100 mg/1 | Archis Pharma LLC | None |
| 0832-0533 | imatinib mesylate | tablet | 400 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 67184-0533 | imatinib mesylate | tablet | 400 mg/1 | Qilu Pharmaceutical Co., Ltd. | None |
| 72819-186 | imatinib mesylate | tablet | 400 mg/1 | Archis Pharma LLC | None |
| 0093-7629 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Teva Pharmaceuticals USA, Inc. | None |
| 0378-2245 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Mylan Pharmaceuticals Inc. | None |
| 0904-6901 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Major Pharmaceuticals | None |
| 31722-296 | IMATINIB MESYLATE | tablet, film coated | 100 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 42292-043 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Mylan Institutional Inc | None |
| 47335-472 | imatinib mesylate | tablet, film coated | 100 mg/1 | Sun Pharmaceutical Industries, Inc. | None |
| 48433-049 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Safecor Health, LLC | None |
| 51407-269 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Golden State Medical Supply, Inc. | None |
| 59651-240 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Aurobindo Pharma Limited | None |
| 60505-2900 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Apotex Corp | None |
| 60687-882 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | American Health Packaging | None |
| 62135-658 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | Chartwell RX, LLC | None |
| 67877-633 | Imatinib mesylate | tablet, film coated | 100 mg/1 | Ascend Laboratories, LLC | None |
| 68001-490 | imatinib mesylate | tablet, film coated | 100 mg/1 | BluePoint Laboratories | None |
| 68001-622 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | BluePoint Laboratories | None |
| 72485-202 | Imatinib mesylate | tablet, film coated | 100 mg/1 | Armas Pharmaceuticals Inc. | None |
| 82009-086 | Imatinib Mesylate | tablet, film coated | 100 mg/1 | QUALLENT PHARMACEUTICALS HEALTH LLC | None |
| 82249-020 | IMATINIB MESYLATE | tablet, film coated | 100 mg/1 | Civica Script LLC | None |
| 0093-7630 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Teva Pharmaceuticals USA, Inc. | None |
| 0378-2246 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Mylan Pharmaceuticals Inc. | None |
| 0904-6621 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Major Pharmaceuticals | None |
| 31722-297 | IMATINIB MESYLATE | tablet, film coated | 400 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 42292-044 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Mylan Institutional Inc | None |
| 47335-475 | imatinib mesylate | tablet, film coated | 400 mg/1 | Sun Pharmaceutical Industries, Inc. | None |
| 48433-050 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Safecor Health, LLC | None |
| 51407-270 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Golden State Medical Supply, Inc. | None |
| 59651-241 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Aurobindo Pharma Limited | None |
| 60505-2901 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Apotex Corp | None |
| 62135-659 | Imatinib Mesylate | tablet, film coated | 400 mg/1 | Chartwell RX, LLC | None |
| 67877-634 | Imatinib mesylate | tablet, film coated | 400 mg/1 | Ascend Laboratories, LLC | None |
Showing 40 of 45 listings.
Questions
Is imatinib a controlled substance?
No. Imatinib is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and imatinib is not on the DEA controlled substances list.
Is imatinib a narcotic?
No. Imatinib is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Kinase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.